The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Research works printed but not linked: 48
- Vansteenkiste, 2001, The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology, Eur Respir J, 17, 802, 10.1183/09031936.01.17408020 · DOI
- Woodard, 1975, Expression of tissue isotope distribution, J Nucl Med, 16, 958
- Fischer, 2001, Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review, Lancet Oncol, 2, 659, 10.1016/S1470-2045(01)00555-1 · DOI · Paper page
- Gould, 2001, Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis, JAMA, 285, 914, 10.1001/jama.285.7.914 · DOI · Paper page
- Dwamena, 1999, Metastases from non-small cell lung cancer: mediastinal staging in the 1990s. Meta-analytic comparison of PET and CT, Radiology, 213, 530, 10.1148/radiology.213.2.r99nv46530 · DOI · Paper page
- Toloza, 2003, Noninvasive staging of nonsmall cell lung cancer: a review of the current evidence, Chest, 123, S137, 10.1378/chest.123.1_suppl.137S · DOI · Paper page
- Pieterman, 2000, Preoperative staging of non-small cell lung cancer with positron emission tomography, N Engl J Med, 343, 254, 10.1056/NEJM200007273430404 · DOI · Paper page
- Duhaylongsod, 1995, Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography, Ann Thorac Surg, 60, 1348, 10.1016/0003-4975(95)00754-9 · DOI · Paper page
- Ahuja, 1998, The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma, Cancer, 83, 918, 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y · DOI · Paper page
- Vansteenkiste, 1999, Prognostic importance of the Standardized Uptake Value on FDG-PET-scan in non-small cell lung cancer: an analysis of 125 cases, J Clin Oncol, 17, 3201, 10.1200/JCO.1999.17.10.3201 · DOI · Paper page
- Dhital, 2000, [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer, Eur J Cardiothorac Surg, 18, 425, 10.1016/S1010-7940(00)00535-2 · DOI
- Higashi, 2002, 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer, J Nucl Med, 43, 39
- Jeong, 2002, Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer, Nucl Med Commun, 23, 865, 10.1097/00006231-200209000-00010 · DOI
- Dunagan, 2001, Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer, Chest, 119, 333, 10.1378/chest.119.2.333 · doi:10.1378/chest.119.2.333
- MacManus, 2001, F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma: powerful correlation with survival and high impact on treatment, Cancer, 92, 886, 10.1002/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V · doi:10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v
- MacManus, 2002, Early mortality after radical radiotherapy for non-small cell lung cancer: comparison of PETstaged and conventionally staged cohorts treated at a large tertiary referral center, Int J Radiat Oncol Biol Phys, 52, 351, 10.1016/S0360-3016(01)02673-6 · doi:10.1016/s0360-3016(01)02673-6
- Hoekstra, 2003, The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment, Lung Cancer, 39, 151, 10.1016/S0169-5002(02)00446-4 · doi:10.1016/s0169-5002(02)00446-4
- Feinstein, 1985, The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer, N Engl J Med, 312, 1604, 10.1056/NEJM198506203122504 · DOI · Paper page
- The International Adjuvant Lung Cancer Trial Collaborative Group, 2004, Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer, N Engl J Med, 350, 351, 10.1056/NEJMoa031644 · DOI · Paper page
- Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 · DOI · Paper page
- Higashi, 1993, Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake, J Nucl Med, 34, 414
- Ichiya, 1996, A clinical evaluation of FDGPET to assess the response in radiation therapy for bronchogenic carcinoma, Ann Nucl Med, 10, 193, 10.1007/BF03165392 · DOI
- Choi, 2002, Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 54, 1024, 10.1016/S0360-3016(02)03038-9 · DOI
- MacManus, 2003, Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small cell lung cancer, J Clin Oncol, 21, 1285, 10.1200/JCO.2003.07.054 · DOI · Paper page
- Weber, 2003, Positron emission tomography in non-small cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use, J Clin Oncol, 21, 2651, 10.1200/JCO.2003.12.004 · DOI · Paper page
- Hoekstra, 2002, Methods to monitor response to chemotherapy in non-small cell lung cancer with 18FFDG PET, J Nucl Med, 43, 1304
- Young, 1999, Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations, Eur J Cancer, 35, 1773, 10.1016/S0959-8049(99)00229-4 · DOI · Paper page
- Bueno, 2001, Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival, Ann Thorac Surg, 70, 1826, 10.1016/S0003-4975(00)01585-X · DOI · Paper page
- Voltolini, 2001, Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy, Eur J Cardiothorac Surg, 20, 1106, 10.1016/S1010-7940(01)00984-8 · doi:10.1016/s1010-7940(01)00984-8
- Margaritora, 2001, Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?, Eur J Cardiothorac Surg, 19, 894, 10.1016/S1010-7940(01)00697-2 · doi:10.1016/s1010-7940(01)00697-2
- Vansteenkiste, 1998, Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients, J Clin Oncol, 16, 2142, 10.1200/JCO.1998.16.6.2142 · DOI · Paper page
- Vansteenkiste, 1998, Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIA-N2 non-small cell lung cancer: a prospective pilot study, Ann Oncol, 9, 1193, 10.1023/A:1008437915860 · DOI
- Akhurst, 2002, An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer, Ann Thorac Surg, 73, 259, 10.1016/S0003-4975(01)03257-X · DOI
- Ryu, 2002, FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology, Lung Cancer, 35, 179, 10.1016/S0169-5002(01)00332-4 · DOI · Paper page
- Cerfolio, 2003, Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma, J Thorac Cardiovasc Surg, 125, 938, 10.1067/mtc.2003.381 · doi:10.1067/mtc.2003.381
- Vansteenkiste, 2001, 18fluoro-2- deoxyglucose positron emission tomography (PET) in the assessment of induction chemotherapy (IC) in stage IIIA-N2 NSCLC: a multicenter prospective study, Proc Am Soc Clin Oncol, 20, A313
- Vesselle, 2002, The impact of fluorodeoxyglucose F18 positron emission tomography on the surgical staging of non-small cell lung cancer, J Thorac Cardiovasc Surg, 124, 511, 10.1067/mtc.2002.123130 · DOI
- Patz, 2000, Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer, AJR Am J Roentgenol, 174, 769, 10.2214/ajr.174.3.1740769 · doi:10.2214/ajr.174.3.1740769
- Hicks, 2001, The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: Impact on management and prognostic stratification, J Nucl Med, 42, 1605
- Pandit, 2003, Prognostic value of [(18)F]FDG-PET imaging in small cell lung cancer, Eur J Nucl Med Mol Imaging, 30, 78, 10.1007/s00259-002-0937-8 · doi:10.1007/s00259-002-0937-8
- Kubota, 1993, Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study, Eur J Nucl Med, 20, 495, 10.1007/BF00175162 · DOI
- Patz, 1994, Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy- D-glucose, Radiology, 191, 379, 10.1148/radiology.191.2.8153309 · DOI
- Duhaylongsod, 1995, Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET), J Thorac Cardiovasc Surg, 110, 130, 10.1016/S0022-5223(05)80018-2 · DOI · Paper page
- Frank, 1995, Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings, Int J Radiat Oncol Biol Phys, 32, 1495, 10.1016/0360-3016(94)00622-R · DOI
- Inoue, 1995, Detecting recurrent or residual lung cancer with FDG-PET, J Nucl Med, 36, 788
- Bury, 1999, Value of FDG-PET in detecting residual or recurrent non-small cell lung cancer, Eur Respir J, 14, 1376, 10.1183/09031936.99.14613769 · DOI
- Ukena, 2000, Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma, Pneumologie, 54, 49, 10.1055/s-2000-9063 · doi:10.1055/s-2000-9063
- Lee, 2001, Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review, Chest, 120, 1791, 10.1378/chest.120.6.1791 · doi:10.1378/chest.120.6.1791
Cited by
Acid-Mediated Tumor Invasion: a Multidisciplinary Study
Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771
van Meerbeeck, J. P., Kramer, G. W. P. M., Van Schil, P. E. Y., Legrand, C., Smit, E. F., Schramel, F., Tjan-Heijnen, V. C., Biesma, B., Debruyne, C., van Zandwijk, N., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk093 · Cited by 705
(2005) · PubMed · Cited by 612
Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007
MacManus, M., Nestle, U., Rosenzweig, K. E., Carrio, I., Messa, C., Belohlavek, O., Danna, M., Inoue, T., Deniaud-Alexandre, E., Schipani, S., et al. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.11.008 · Cited by 367
Westerterp, M., Pruim, J., Oyen, W., Hoekstra, O., Paans, A., Visser, E., van Lanschot, J., Sloof, G., & Boellaard, R. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0224-1 · Cited by 294
Metadata
- Authors
- Vansteenkiste, J., Fischer, B. M., Dooms, C., & Mortensen, J.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 5
- Issue
- 9
- Pages
- 531-540
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2143000781
- Cited by
- 231
- References
- 1
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. https://app.cochat.ai/papers/10.1016/s1470-2045(04)01564-5
- The paper
- Vansteenkiste, J., Fischer, B. M., Dooms, C., & Mortensen, J. (2004). Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(04)01564-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.